Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Hippocampal Temporal Interference Stimulation for Memory and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

sunnuntai 8. marraskuuta 2026 päivittänyt: Jiaojiao Lü, PhD, Shanghai University of Sport

Effects and Underlying Mechanisms of Hippocampal-Targeted Temporal Interference Stimulation on Memory Function and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

This randomized crossover study aims to investigate the immediate effects of hippocampal temporal interference stimulation (TIS) on memory and dual-task postural control in older adults with mild cognitive impairment (MCI).

Participants are assigned to receive three stimulation conditions: 40 Hz TIS, 5 Hz TIS, and sham stimulation. Each condition is administered in a separate session in a randomized order, with at least 7 days between consecutive sessions.

The study compares memory and dual-task postural control across the three stimulation conditions. Memory and dual-task postural control assessments are planned before and after each stimulation session.

Tutkimuksen yleiskatsaus

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

21

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

  • Nimi: Jiaojiao Lü, PhD
  • Puhelinnumero: +86 18516565889
  • Sähköposti: ljj27@163.com

Opiskelupaikat

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kiina, 200438
        • Rekrytointi
        • Shanghai University of Sport
        • Ottaa yhteyttä:
          • Ethics Committee of the Shanghai University of Sport
          • Puhelinnumero: +86 21 65508179
          • Sähköposti: lunli@sus.edu.cn

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

65 vuotta ja vanhemmat (Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

  1. Age 65 years or older.
  2. Presence of subjective memory complaints.
  3. Objective cognitive impairment, defined as a corrected MoCA-BJ total score of less than 26. The MoCA-BJ has a maximum score of 30. For participants with no more than 12 years of education, 1 point is added to the raw score, and the corrected total score is capped at 30 points.
  4. Global Clinical Dementia Rating (CDR) score of 0.5.
  5. No diagnosis of dementia, with an MMSE score of at least 18 for illiterate participants, at least 21 for those with primary school education, and at least 25 for those with junior high school education or above.
  6. Remains independent in activities of daily living (ADL) and is able to cooperate with all assessments and interventions.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Crossover-tehtävä
  • Naamiointi: Kaksinkertainen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: 40 Hz Temporal Interference Stimulation

Participants receive one 20-minute session of active 40 Hz temporal interference stimulation (TIS) targeting the left hippocampus. In this randomized crossover study, participants are also assigned to receive 5 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 40 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Muut nimet:
  • TIs
Huijausvertailija: sham group

Participants receive one 20-minute session of sham temporal interference stimulation (TIS), using the same electrode placement and setup as the 40 Hz TIS session. In this randomized crossover study, participants are also assigned to receive 40 Hz and 5 Hz TIS in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the sham stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Muut nimet:
  • TIs
Kokeellinen: 5 Hz Temporal Interference Stimulation

Participants receive one session of active 5 Hz temporal interference stimulation (TIS). In this randomized crossover study, participants are also assigned to receive 40 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 5 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Muut nimet:
  • TIs

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Accuracy After Stimulation
Aikaikkuna: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized object-scene associative memory task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct match/non-match responses divided by the total number of valid retrieval trials and multiplied by 100. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Reaction Time After Stimulation
Aikaikkuna: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the object-scene associative memory task. Mean reaction time is calculated using valid trials with correct responses. Trials with no response or reaction times shorter than 300 milliseconds are excluded. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change From Pre-intervention in Word Recognition Accuracy After Stimulation
Aikaikkuna: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized word-recognition task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct responses divided by the total number of analyzed trials and multiplied by 100. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Word Recognition Reaction Time After Stimulation
Aikaikkuna: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the word-recognition task. Mean reaction time is calculated using valid trials with correct responses. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 3-Meter Timed Up and Go Completion Time After Stimulation
Aikaikkuna: Immediately before and after each 20-minute stimulation session during each crossover period

Participants perform the 3-meter Timed Up and Go test under single-task and dual-task conditions. During the dual-task condition, participants complete the test while continuously subtracting 3 from a randomly selected three-digit number. Total completion time is measured in seconds using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean completion time is used. Dual-task cost is calculated as: [(dual-task completion time - single-task completion time) / single-task completion time] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates greater deterioration in mobility performance under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 7-Meter Walking Speed After Stimulation
Aikaikkuna: Immediately before and after each 20-minute stimulation session during each crossover period

Participants complete the 7-meter walking test at their usual comfortable speed under single-task and dual-task conditions. During the dual-task condition, participants walk while continuously subtracting 3 from a randomly selected three-digit number. Walking speed is measured in meters per second using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean walking speed is used. Dual-task cost is calculated as: [(single-task walking speed - dual-task walking speed) / single-task walking speed] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates a greater reduction in walking speed under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Number of Participants With Any Stimulation-Associated Adverse Symptom
Aikaikkuna: During and immediately after each 20-minute stimulation session in each crossover period

Safety is assessed using a standardized adverse-reaction questionnaire completed immediately after each stimulation session. Prespecified symptoms include tingling, itching, burning sensation, pain, skin redness, fatigue, visual sensations, difficulty concentrating, and mood changes. Each symptom is rated as none, mild, moderate, or severe, corresponding to scores of 0, 1, 2, and 3, respectively. Other spontaneously reported symptoms are also recorded. For each stimulation condition, a participant is counted as having an adverse symptom if at least one prespecified or spontaneously reported symptom is present with a severity score of 1 or higher during or immediately after stimulation.

During and immediately after each 20-minute stimulation session in each crossover period

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Torstai 30. heinäkuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Torstai 15. heinäkuuta 2027

Opintojen valmistuminen (Arvioitu)

Perjantai 30. heinäkuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Lauantai 8. elokuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Torstai 13. elokuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Tiistai 18. elokuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Torstai 12. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Sunnuntai 8. marraskuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. marraskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa